Zimmer Biomet Reports Q3 Earnings Beat on Revenue and EPS
Zimmer Biomet (ZBH) reported third-quarter financial results that exceeded market expectations. The company posted a Non-GAAP earnings per share (EPS) of $1.90, surpassing consensus estimates by $0.02, while revenue reached $2.06 billion, representing a 3.0% year-over-year increase and beating projections by $20 million. Looking ahead to the fiscal year ending December 31, 2026, market consensus anticipates revenue growth of 4.43% and an EPS of $9.05. The results demonstrate steady top-line growth and operational efficiency in meeting profitability targets.
Tickers: $ZBH